Formed in 2001, Ocutec Limited have delivered notable proof of concept, investment and commercialization milestones.
The assembled team have combined to form an undoubtedly world-class scientific and management board. The company's IPR inventory features numerous granted patents to secure a strong position in the dynamic contact lens market place. Ocutec's manufactured hydrogel formulations have demonstrated clinically relevant superior bulk and surface properties and importantly have confirmed that the target “5 cent” price is achieveable.